What is the value of autologous bone marrow transplantation in the treatment of relapsed or resistant hodgkin's disease?
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 15 (4) , 237-243
- https://doi.org/10.1016/0145-2126(91)90126-e
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site.Journal of Clinical Oncology, 1990
- High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphomaBlood, 1989
- Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantationBlood, 1989
- High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's diseaseBritish Journal of Cancer, 1989
- Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.Journal of Clinical Oncology, 1989
- Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantationBlood, 1989
- High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.Journal of Clinical Oncology, 1988
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- MIME chemotherapy (methyl-GAG, ifosfamide, methotrexate, etoposide) as treatment for recurrent Hodgkin's disease.Journal of Clinical Oncology, 1987
- Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's DiseaseAnnals of Internal Medicine, 1986